← Leaderboards
James A Bonner
University Of Alabama At Birmingham
$1,167,061
Attributed
$1,167,061
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,167,061 · 3
By mechanism
R01$954,276 · 1
R29$212,785 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Ralph R Weichselbaum$16,065,057
- Jeffrey Allen Engler$4,295,283
- Albert F Lobuglio$1,259,317
- Donald J Buchsbaum$5,699,601
- Candece L Gladson$9,713,401
Others in their field
Top investigators on “Epidermal Growth Factor”
- Norman Wolmark · Nsabp Foundation, Inc.$27,726,714
- Walter John Curran · Thomas Jefferson University$26,641,549
- Robert J Coffey · Vanderbilt University$24,542,527
- Pasi A Janne · Stanford University$23,416,433
- John H Sampson · Duke University$22,281,972
- Elaine Fuchs · University Of Chicago$21,320,660
Research focus
Epidermal Growth FactorGrowth Factor ReceptorsRadiation SensitivityRadiosensitizerHead /Neck NeoplasmCombination Cancer TherapyMonoclonal AntibodyImmunologic Substance Development /PreparationAthymic MouseGene Delivery SystemGene TargetingGene TherapyNonhuman Therapy EvaluationNeoplasm /Cancer Radiation TherapyBiotechnologyAdenoviridaeApoptosisGene ExpressionWestern BlottingsCell CycleCytotoxicityDigestive NeoplasmDna TopoisomerasesDrug Interactions
Grant awards (7)
Radiosensitization with Recombinant Antibodies to EGFr$238,569
R01 · FY2005 · CA
Radiosensitization with Recombinant Antibodies to EGFr$238,569
R01 · FY2004 · CA
Radiosensitization with Recombinant Antibodies to EGFr$238,569
R01 · FY2003 · CA
Radiosensitization with Recombinant Antibodies to EGFr$238,569
R01 · FY2002 · CA
PROLIFERATIVE RESPONSE TO RADIATION AND ETOPOSIDE$108,478
R29 · FY2001 · CA
PROLIFERATIVE RESPONSE TO RADIATION AND ETOPOSIDE$104,307
R29 · FY2000 · CA
RADIATION THERAPY VS ANTI EGFR ANTIBODY C225 IN SCC$0
M01 · FY2000 · RR